Eribulin for breast cancer: Positive effects predominate in certain patients, negativ

[News]

Proof of minor added benefit in one patient group / Hint or indication of lesser benefit in othersEribulin (trade name: Halaven) is approved for women with locally advanced or metastatic breast...

More... (http://www.medicalnewstoday.com/releases/285152.php)